Abstract

The stability of teniposide in various diluents and polyvinyl chloride bags was determined, and the extent of leaching of di(2-ethylhexyl) phthalate (DEHP) from PVC bags caused by the teniposide formulation was measured. No significant drug loss was observed during simulated infusions ( n = 4) for 1 h using PVC infusion bags and administration sets. No significant difference was found between infusion solutions (5% glucose or 0.9% Nacl). To minimize patient exposure to DEHP, teniposide solutions may be stored in a glass or polyolefin container and delivered through polyethylene-lined i.v. administration sets. If PVC bags are used for preparing teniposide solutions, the injections must be used immediately after preparation or stored 4–5 h at + 4°C.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call